annual cash & cash equivalents:
$196.81M+$167.65M(+574.98%)Summary
- As of today (September 16, 2025), MAZE annual cash & cash equivalents is $196.81 million, with the most recent change of +$167.65 million (+574.98%) on December 31, 2024.
- During the last 3 years, MAZE annual cash & cash equivalents has risen by +$96.89 million (+96.97%).
- MAZE annual cash & cash equivalents is now at all-time high.
Performance
MAZE Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$264.54M-$29.83M(-10.13%)Summary
- As of today (September 16, 2025), MAZE quarterly cash & cash equivalents is $264.54 million, with the most recent change of -$29.83 million (-10.13%) on June 30, 2025.
- Over the past year, MAZE quarterly cash & cash equivalents has increased by +$89.48 million (+51.11%).
- MAZE quarterly cash & cash equivalents is now -10.13% below its all-time high of $294.37 million, reached on March 31, 2025.
Performance
MAZE quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MAZE Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +575.0% | +51.1% |
| 3 y3 years | +97.0% | - |
| 5 y5 years | +97.0% | - |
MAZE Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +575.0% | -10.1% | +807.3% |
| 5 y | 5-year | at high | +575.0% | -10.1% | +807.3% |
| alltime | all time | at high | +575.0% | -10.1% | +807.3% |
MAZE Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $264.54M(-10.1%) |
| Mar 2025 | - | $294.37M(+49.6%) |
| Dec 2024 | $196.81M | $196.81M(+31.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $149.61M(-14.5%) |
| Jun 2024 | - | $175.06M(+500.4%) |
| Dec 2023 | $29.16M(-70.8%) | $29.16M |
| Dec 2022 | $99.92M | - |
FAQ
- What is Maze Therapeutics, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Maze Therapeutics, Inc.?
- What is Maze Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Maze Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Maze Therapeutics, Inc.?
- What is Maze Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Maze Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of MAZE is $196.81M
What is the all time high annual cash & cash equivalents for Maze Therapeutics, Inc.?
Maze Therapeutics, Inc. all-time high annual cash & cash equivalents is $196.81M
What is Maze Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, MAZE annual cash & cash equivalents has changed by +$167.65M (+574.98%)
What is Maze Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MAZE is $264.54M
What is the all time high quarterly cash & cash equivalents for Maze Therapeutics, Inc.?
Maze Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $294.37M
What is Maze Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, MAZE quarterly cash & cash equivalents has changed by +$89.48M (+51.11%)